The impact of full-thickness chondral defects (FTD) on outcomes after meniscus allograft transplantation (MAT) remains unknown. The purpose of this study was to determine the impact of FTD on outcomes following MAT. Methods: Patients undergoing MAT between 9/1997-3/2013 with minimum two-year follow-up were identified and split into two groups based upon presence or absence of FTD identified intra-operatively: No defect ("ND", Outerbridge Grade 0/I) or FTD (Outerbridge Grade IV). All FTD were treated with cartilage restoration procedures (microfracture, osteochondral allo/autograft, DeNovo or autologous chondrocyte implantation). Reoperations, failures (revision MAT or conversion to arthroplasty), and patient-reported outcomes (PROs) were reported at sixmonths, one-year, two-years and final follow-up. Inter-group comparisons were made using unpaired student ttests. Results: A total of 91 patients -22 with ND and 69 with a FTD were identified and followed for a mean 4.48 and 3.84 years, respectively. There were no significant between-group differences in age, body mass index (BMI), or number of prior surgeries. One complication occurred in the FTD group (1.3%), and no complications in the ND group. There were no significant differences in number of subsequent surgeries or failures. Comparison of the cohorts found no differences in PROs preoperatively. At 6-months postoperative, significantly greater values were reported in the FTD cohort for KOOS-Pain and KOOS-ADL and greater values for the ND cohort for WOMACFunction and WOMAC-Total. At 1-year postoperative, significantly greater values were reported for the ND cohort for KOOS-Symptoms and KOOS-QOL, but at 2-years postoperative and final follow-up, no further significant differences in any PROs were present. At final follow-up, the ND and FTD cohorts reported significant improvements in the majority of PRO categories, with a greater number of PRO subscales demonstrating significance in the FTD group (Figure 1 ; Table 1) . Conclusion: FTD when treated at the time of MAT have no significant influence on outcome following MAT, including PROs, failures or reoperations. Clinicians performing MAT in meniscus deficient patients with fullthickness chondral defects should counsel their patients that if these defects are treated concomitantly with MAT that they can expect similar outcomes to patients without full-thickness chondral defects at long-term follow-up.
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